{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:25:01Z","timestamp":1787585101195,"version":"build-2736575974"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Brain"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Brain tumours, particularly glioblastoma, remain among the most lethal cancers due to considerable spatial variation, metabolic adaptability, immune suppression, and resistance to standard therapies. Ferroptosis, an iron-dependent form of regulated cell death driven by lipid peroxidation, presents a candidate target for new treatments in these tumours. This review examines ferroptosis as an immunometabolic checkpoint in brain tumours, emphasising how iron metabolism, glutathione depletion, lipid remodelling, and microenvironmental factors influence vulnerability across different regions. Using the SANRA framework, relevant studies from major sources were analysed to compile mechanistic, preclinical, and translational insights across glioblastoma and other brain tumour types. Evidence shows that brain tumours often activate ferroptosis-inhibiting pathways, including GPX4,\n                    <jats:italic>SLC7A11<\/jats:italic>\n                    , and\n                    <jats:italic>NRF2<\/jats:italic>\n                    , to promote survival, invasion, and therapy resistance. At the same time, recurrent or treatment-persistent tumour states may develop specific weaknesses to ferroptosis, especially in metabolically stressed or dormant cell populations. Ferroptosis interacts with immune responses: CD8\u2009+\u2009T-cell-derived IFN-\u03b3 can trigger tumour ferroptosis, although this process may also foster immunosuppressive microenvironments depending on the context. Spatial heterogeneity adds complexity, as hypoxic tumour cores, invasive edges, and perivascular areas vary in oxidative stress, lipid metabolism, immune cell presence, and drug access. In conclusion, ferroptosis acts both as a tumour survival mechanism and as a potential vulnerability to target. Progress depends on integrating spatial and single-cell approaches, biomarker-driven patient stratification, and delivery methods that consider the blood-brain barrier to effectively and safely induce ferroptosis. This strategy highlights ferroptosis as a key focus for personalised neuro-oncology and combination therapy development.\n                  <\/jats:p>","DOI":"10.1186\/s13041-026-01344-9","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:26:53Z","timestamp":1787581613000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ferroptosis as an immunometabolic checkpoint in brain tumours: spatial vulnerabilities and therapeutic opportunities"],"prefix":"10.1186","volume":"19","author":[{"given":"Maher","family":"Nassor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saim","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahmida","family":"Zahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subham","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay Paulina K.","family":"Odei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Princess Afia","family":"Nkrumah-Boateng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Awuah","family":"Wireko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"1344_CR1","doi-asserted-by":"publisher","first-page":"19228","DOI":"10.1038\/s41598-025-04636-7","volume":"15","author":"J Zhou","year":"2025","unstructured":"Zhou J, Gu L, Du F, et al The global, regional, and national brain and CNS cancers burden and trends from 1990 to 2021. Sci Rep. 2025;15:19228. https:\/\/doi.org\/10.1038\/s41598-025-04636-7.","journal-title":"Sci Rep"},{"issue":"5","key":"1344_CR2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3322\/caac.21693","volume":"71","author":"KD Miller","year":"2021","unstructured":"Miller KD, Ostrom QT, Kruchko C, Patil N, Tihan T, Cioffi G, Fuchs HE, Waite KA, Jemal A, Siegel RL, Barnholtz-Sloan JS. Brain and other central nervous system tumor statistics, 2021. Cancer J Clin. 2021;71(5):381\u2013406. https:\/\/doi.org\/10.3322\/caac.21693.","journal-title":"Cancer J Clin"},{"key":"1344_CR3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.wneu.2020.03.150","volume":"138","author":"X Zhou","year":"2020","unstructured":"Zhou X, Niu X, Li J, Zhang S, Yang W, Yang Y, Mao Q, Liu Y. Risk factors for early mortality in patients with primary central nervous system lymphoma: a large-cohort retrospective study. World Neurosurg. 2020a;138:e1\u201310. https:\/\/doi.org\/10.1016\/j.wneu.2020.03.150.","journal-title":"World Neurosurg"},{"key":"1344_CR4","doi-asserted-by":"publisher","first-page":"1614549","DOI":"10.3389\/fimmu.2025.1614549","volume":"16","author":"S Ma","year":"2025","unstructured":"Ma S, Sun Y, Zheng S, Fu Y, Wang L, Liu D, Jiao H, Zhu X, Li X, Yan D, Chen D, Ye Z Single-cell and spatial atlas of glioblastoma heterogeneity: characterizing the PCLAF+ subtype and YEATS4\u2019s oncogenic role. Front Immunol. 2025;16:1614549. https:\/\/doi.org\/10.3389\/fimmu.2025.1614549.","journal-title":"Front Immunol"},{"issue":"1","key":"1344_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.22034\/APJCP.2017.18.1.3","volume":"18","author":"F Hanif","year":"2017","unstructured":"Hanif F, Muzaffar K, Perveen K, Malhi SM, Simjee SU. Glioblastoma multiforme: a review of its epidemiology and pathogenesis through clinical presentation and treatment. Asian Pac J Cancer Prev. 2017;18(1):3\u20139. https:\/\/doi.org\/10.22034\/APJCP.2017.18.1.3.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1344_CR6","doi-asserted-by":"publisher","first-page":"112913","DOI":"10.1016\/j.ejca.2023.05.002","volume":"189","author":"C Le Hertler","year":"2023","unstructured":"Hertler C, Felsberg J, Gramatzki D, Le Rhun E, Clarke J, Soffietti R, Wick W, Chinot O, Ducray F, Roth P, McDonald K, Hau P, Hottinger AF, Reijneveld J, Schnell O, Marosi C, Glantz M, Darlix A, Lombardi G, Weller M. Long-term survival with IDH wildtype glioblastoma: first results from the eternity brain tumor funders\u2019 collaborative consortium (EORTC 1419). Eur J Cancer. 2023;189:112913. https:\/\/doi.org\/10.1016\/j.ejca.2023.05.002.","journal-title":"Eur J Cancer"},{"issue":"12","key":"1344_CR7","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.3390\/cancers16122249","volume":"16","author":"H Slika","year":"2024","unstructured":"Slika H, Shahani A, Wahi R, Miller J, Groves M, Tyler B. Overcoming treatment resistance in medulloblastoma: underlying mechanisms and potential strategies. Cancers. 2024;16(12):2249. https:\/\/doi.org\/10.3390\/cancers16122249.","journal-title":"Cancers"},{"issue":"11","key":"1344_CR8","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3390\/antiox14111373","volume":"14","author":"A Schwantes","year":"2025","unstructured":"Schwantes A, Shadid Y, Guerrero Ruiz VM, Aliraj B, Wickert A, Palmer MA, Meyer SP, Weigert A, Br\u00fcne B, Fuhrmann DC. Ferroptosis enhances T lymphocyte infiltration into glioblastoma spheroids. Antioxidants. 2025;14(11):1373. https:\/\/doi.org\/10.3390\/antiox14111373.","journal-title":"Antioxidants"},{"key":"1344_CR9","doi-asserted-by":"publisher","first-page":"1342114","DOI":"10.3389\/fonc.2024.1342114","volume":"14","author":"R Weber","year":"2024","unstructured":"Weber R, Weller M, Reifenberger G, Vasella F. Epigenetic modification and characterization of the MGMT promoter region using CRISPRoff in glioblastoma cells. Front Oncol. 2024;14:1342114. https:\/\/doi.org\/10.3389\/fonc.2024.1342114.","journal-title":"Front Oncol"},{"issue":"3","key":"1344_CR10","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s11060-025-04952-y","volume":"172","author":"J Pham","year":"2025","unstructured":"Pham J, Cote DJ, Kang K, Briggs RG, Gomez D, Prasad A, Daggupati S, Sisti J, Chow F, Attenello F, Chen CC, Zada G. Treatment practices and survival outcomes for IDH-wildtype glioblastoma patients according to MGMT promoter methylation status: insights from the U.S. National Cancer Database. J Neurooncol. 2025;172(3):655\u201365. https:\/\/doi.org\/10.1007\/s11060-025-04952-y.","journal-title":"J Neurooncol"},{"issue":"5","key":"1344_CR11","doi-asserted-by":"publisher","first-page":"112472","DOI":"10.1016\/j.celrep.2023.112472","volume":"42","author":"C Garc\u00eda-D\u00edaz","year":"2023","unstructured":"Garc\u00eda-D\u00edaz C, P\u00f6ysti A, Mereu E, Clements MP, Brooks LJ, Galvez-Cancino F, Castillo SP, Tang W, Beattie G, Courtot L, Ruiz S, Roncaroli F, Yuan Y, Marguerat S, Quezada SA, Heyn H, Parrinello S Glioblastoma cell fate is differentially regulated by the microenvironments of the tumor bulk and infiltrative margin. Cell Rep. 2023;42(5):112472. https:\/\/doi.org\/10.1016\/j.celrep.2023.112472.","journal-title":"Cell Rep"},{"issue":"9","key":"1344_CR12","doi-asserted-by":"publisher","first-page":"104872","DOI":"10.1016\/j.isci.2022.104872","volume":"25","author":"C Ye","year":"2022","unstructured":"Ye C, Li H, Li Y, Zhang Y, Liu G, Mi H, Li H, Xiao Q, Niu L, Yu X. Hypoxia-induced HMGB1 promotes glioma stem cell self-renewal and tumorigenicity via RAGE. iScience. 2022;25(9):104872. https:\/\/doi.org\/10.1016\/j.isci.2022.104872.","journal-title":"iScience"},{"issue":"1","key":"1344_CR13","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1038\/s41598-019-38625-4","volume":"9","author":"M van Alieva","year":"2019","unstructured":"Alieva M, Leidgens V, Riemenschneider MJ, Klein CA, Hau P, van Rheenen J Intravital imaging of glioma border morphology reveals distinctive cellular dynamics and contribution to tumor cell invasion. Sci Rep. 2019;9(1):2054. https:\/\/doi.org\/10.1038\/s41598-019-38625-4.","journal-title":"Sci Rep"},{"key":"1344_CR14","doi-asserted-by":"publisher","first-page":"1522392","DOI":"10.3389\/fimmu.2024.1522392","volume":"15","author":"L Yang","year":"2025","unstructured":"Yang L, Li S, Yu L, Leng J, Li N. Targeting glycolysis: exploring a new frontier in glioblastoma therapy. Front Immunol. 2025;15:1522392. https:\/\/doi.org\/10.3389\/fimmu.2024.1522392.","journal-title":"Front Immunol"},{"key":"1344_CR15","doi-asserted-by":"publisher","first-page":"696402","DOI":"10.3389\/fonc.2021.696402","volume":"11","author":"AA Mohan","year":"2021","unstructured":"Mohan AA, Tomaszewski WH, Haskell-Mendoza AP, Hotchkiss KM, Singh K, Reedy JL, Fecci PE, Sampson JH, Khasraw M. Targeting immunometabolism in glioblastoma. Front Oncol. 2021;11:696402. https:\/\/doi.org\/10.3389\/fonc.2021.696402.","journal-title":"Front Oncol"},{"key":"1344_CR16","doi-asserted-by":"publisher","first-page":"001524","DOI":"10.17912\/micropub.biology.001524","volume":"2025","author":"L Neitzel","year":"2025","unstructured":"Neitzel L, Rea S, Cornell J, Williams C, Hong C. Ferroptosis in the U87MG human glioblastoma cell line induces damage-associated molecular phenotypes. Micropubl Biol. 2025;2025:001524. https:\/\/doi.org\/10.17912\/micropub.biology.001524.","journal-title":"Micropubl Biol"},{"issue":"1","key":"1344_CR17","doi-asserted-by":"publisher","first-page":"56930","DOI":"10.1038\/s41467-025-56930-7","volume":"16","author":"S-P de Weathers","year":"2025","unstructured":"Weathers S-P, Li X, Zhu H, Damania AV, Knafl M, McKinley B, Lin H, Harrison RA, Majd NK, O\u2019Brien BJ, Penas-Prado M, Loghin M, Kamiya-Matsuoka C, Yung WK, Soto S, Maru LM, Wistuba DM, Cuentas IP, Hernandez ER, de Groot S, J. F. Improved overall survival in an anti-PD-L1\u2013treated cohort of newly diagnosed glioblastoma patients is associated with distinct immune, mutation, and gut microbiome features: a single-arm prospective phase I\/II trial. Nat Commun. 2025;16(1):56930. . https:\/\/doi.org\/10.1038\/s41467-025-56930-7.","journal-title":"Nat Commun"},{"key":"1344_CR18","doi-asserted-by":"publisher","first-page":"102685","DOI":"10.1016\/j.tranon.2026.102685","volume":"65","author":"Z Wang","year":"2026","unstructured":"Wang Z, Liu H, Liang J, Zhang Y, Cho WC, Ye M, Ma D, Kong M, Zhu C, Shen JFerroptosis induction enhances anti\u2013PD-1 efficacy in non\u2013small cell lung cancer via HIF-1\u03b1\/PD-L1 modulation. Transl Oncol. 2026;65:102685. https:\/\/doi.org\/10.1016\/j.tranon.2026.102685.","journal-title":"Transl Oncol"},{"issue":"1","key":"1344_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","volume":"4","author":"C Baethge","year":"2019","unstructured":"Baethge C, Goldbeck-Wood S, Mertens S SANRA: a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019;4(1):5. https:\/\/doi.org\/10.1186\/s41073-019-0064-8.","journal-title":"Res Integr Peer Rev"},{"key":"1344_CR20","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2018.09.043","volume":"133","author":"T Hirschhorn","year":"2019","unstructured":"Hirschhorn T, Stockwell BR. The development of the concept of ferroptosis. Free Radic Biol Med. 2019;133:130\u201343. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.09.043.","journal-title":"Free Radic Biol Med"},{"issue":"14","key":"1344_CR21","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR. Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022;185(14):2401\u201321. https:\/\/doi.org\/10.1016\/j.cell.2022.06.003.","journal-title":"Cell"},{"issue":"2","key":"1344_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2478\/aiht-2020-71-3366","volume":"71","author":"I \u010cepelak","year":"2020","unstructured":"\u010cepelak I, Dodig S, Dodig D\u010c. Ferroptosis: regulated cell death. Arch Ind Hyg Toxicol. 2020;71(2):99\u2013109. https:\/\/doi.org\/10.2478\/aiht-2020-71-3366.","journal-title":"Arch Ind Hyg Toxicol"},{"issue":"2","key":"1344_CR23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Angeli F, Bayir JP, Bush H, Conrad AI, Dixon M, Fulda SJ, Gasc\u00f3n S, Hatzios S, Kagan SK, Noel VE, Jiang K, Linkermann X, Murphy A, Overholtzer ME, Oyagi M, Pagnussat A, Park GC, Ran J, Q., Rosenfeld CS. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171(2):273\u201385. https:\/\/doi.org\/10.1016\/j.cell.2017.09.021.","journal-title":"Cell"},{"issue":"1","key":"1344_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41420-021-00483-3","volume":"7","author":"B Xie","year":"2021","unstructured":"Xie B, Guo Y. Molecular mechanism of cell ferroptosis and research progress in regulation of ferroptosis by noncoding RNAs in tumor cells. Cell Death Discov. 2021;7(1):101. https:\/\/doi.org\/10.1038\/s41420-021-00483-3.","journal-title":"Cell Death Discov"},{"issue":"2","key":"1344_CR25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11(2):88. https:\/\/doi.org\/10.1038\/s41419-020-2298-2.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1344_CR26","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41420-025-02711-6","volume":"11","author":"H Sun","year":"2025","unstructured":"Sun H, Zhang J, Qi H, Jiang D, Hu C, Mao C, Liu W, Qi H, Zong J Ironing out glioblastoma: ferroptosis mechanisms and therapeutic frontiers. Cell Death Discov. 2025;11(1):407. https:\/\/doi.org\/10.1038\/s41420-025-02711-6.","journal-title":"Cell Death Discov"},{"issue":"5","key":"1344_CR27","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B, Stockwell BR. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042.","journal-title":"Cell"},{"issue":"4","key":"1344_CR28","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266\u201382. https:\/\/doi.org\/10.1038\/s41580-020-00324-8.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"1344_CR29","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.molcel.2018.10.042","volume":"73","author":"M Gao","year":"2019","unstructured":"Gao M, Yi J, Zhu J, Minikes AM, Monian P, Thompson CB, Jiang X. Role of mitochondria in ferroptosis. Mol Cell. 2019;73(2):354\u2013e3633. https:\/\/doi.org\/10.1016\/j.molcel.2018.10.042.","journal-title":"Mol Cell"},{"issue":"9","key":"1344_CR30","doi-asserted-by":"publisher","first-page":"e202105043","DOI":"10.1083\/jcb.202105043","volume":"220","author":"B Gan","year":"2021","unstructured":"Gan B. Mitochondrial regulation of ferroptosis. J Cell Biol. 2021;220(9):e202105043. https:\/\/doi.org\/10.1083\/jcb.202105043.","journal-title":"J Cell Biol"},{"issue":"3","key":"1344_CR31","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Annicchiarico-Petruzzelli M, Antonov AV, Arama E, Baehrecke EH, Barlev NA, Bazan NG, Bernassola F, Bertrand MJM, Bianchi K, Blagosklonny MV. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25(3):486\u2013541. https:\/\/doi.org\/10.1038\/s41418-017-0012-4.","journal-title":"Cell Death Differ"},{"issue":"17","key":"1344_CR32","doi-asserted-by":"publisher","first-page":"2105451","DOI":"10.1002\/advs.202105451","volume":"9","author":"B Li","year":"2022","unstructured":"Li B, et al. Synchronous disintegration of ferroptosis defense axis via engineered exosome-conjugated magnetic nanoparticles for glioblastoma therapy. Adv Sci. 2022;9(17):2105451. https:\/\/doi.org\/10.1002\/advs.202105451.","journal-title":"Adv Sci"},{"key":"1344_CR33","doi-asserted-by":"publisher","first-page":"841418","DOI":"10.3389\/fonc.2022.841418","volume":"12","author":"H Kram","year":"2022","unstructured":"Kram H, Prokop G, Haller B, Gempt J, Wu Y, Schmidt-Graf F, Schlegel J, Conrad M, Liesche-Starnecker F. Glioblastoma relapses show increased markers of vulnerability to ferroptosis. Front Oncol. 2022;12:841418. https:\/\/doi.org\/10.3389\/fonc.2022.841418.","journal-title":"Front Oncol"},{"issue":"1","key":"1344_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1227\/NEU.0b013e318276b2de","volume":"72","author":"S Takeuchi","year":"2013","unstructured":"Takeuchi S, et al. Increased xCT expression correlates with tumor invasion and outcome in patients with glioblastomas. Neurosurgery. 2013;72(1):33\u201341. https:\/\/doi.org\/10.1227\/NEU.0b013e318276b2de.","journal-title":"Neurosurgery"},{"issue":"12","key":"1344_CR35","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1158\/1541-7786.MCR-16-0028","volume":"14","author":"MD Polewski","year":"2016","unstructured":"Polewski MD, Reveron-Thornton RF, Cherryholmes GA, Marinov GK, Cassady K, Aboody KS. Increased expression of System Xc\u2212 in glioblastoma confers an altered metabolic state and temozolomide resistance. Mol Cancer Res. 2016;14(12):1229\u201342. https:\/\/doi.org\/10.1158\/1541-7786.MCR-16-0028.","journal-title":"Mol Cancer Res"},{"key":"1344_CR36","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s12672-022-00556-4","volume":"13","author":"WA Awuah","year":"2022","unstructured":"Awuah WA, Toufik A-R, Yarlagadda R, Mikhailova T, Mehta A, Huang H, et al. Exploring the role of Nrf2 signaling in glioblastoma multiforme. Discov Oncol. 2022;13:94. https:\/\/doi.org\/10.1007\/s12672-022-00556-4.","journal-title":"Discov Oncol"},{"key":"1344_CR37","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41420-025-02744-x","volume":"11","author":"S Singh","year":"2025","unstructured":"Singh S, Mohapatra I, Barik D, Zheng H, Kim S, Sharma M, et al. Harnessing ferroptosis to transform glioblastoma therapy and surmount treatment resistance. Cell Death Discov. 2025;11:448. https:\/\/doi.org\/10.1038\/s41420-025-02744-x.","journal-title":"Cell Death Discov"},{"key":"1344_CR38","doi-asserted-by":"publisher","first-page":"993316","DOI":"10.3389\/fonc.2022.993316","volume":"12","author":"J Shi","year":"2022","unstructured":"Shi J, Yang N, Han M, Qiu C Emerging roles of ferroptosis in glioma. Front Oncol. 2022;12:993316. https:\/\/doi.org\/10.3389\/fonc.2022.993316.","journal-title":"Front Oncol"},{"key":"1344_CR39","doi-asserted-by":"publisher","first-page":"1346585","DOI":"10.3389\/fimmu.2024.1346585","volume":"15","author":"H Wang","year":"2024","unstructured":"Wang H, Liu Y, Che S, Li X, Tang D, Lv S, et al. Deciphering the link: ferroptosis and its role in glioma. Front Immunol. 2024;15:1346585. https:\/\/doi.org\/10.3389\/fimmu.2024.1346585.","journal-title":"Front Immunol"},{"issue":"2","key":"1344_CR40","doi-asserted-by":"publisher","first-page":"12636","DOI":"10.1080\/21655979.2021.2011633","volume":"12","author":"X Zhao","year":"2021","unstructured":"Zhao X, Zhou M, Yang Y, Luo M. The ubiquitin hydrolase OTUB1 promotes glioma cell stemness via suppressing ferroptosis through stabilizing SLC7A11 protein. Bioengineered. 2021;12(2):12636\u201345. https:\/\/doi.org\/10.1080\/21655979.2021.2011633.","journal-title":"Bioengineered"},{"issue":"20","key":"1344_CR41","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1038\/s44318-024-00176-4","volume":"43","author":"MA Banu","year":"2024","unstructured":"Banu MA, Dovas A, Argenziano MG, Zhao W, Sperring CP, Grajal C, Liu H, Higgins Z, Amini DM, Pereira M, Ye B, Mahajan LF, Humala A, Furnari N, Upadhyayula JL, Zandkarimi PS, Nguyen F, Teasley TT, Wu D, P. B., Hai L. A cell state-specific metabolic vulnerability to GPX4-dependent ferroptosis in glioblastoma. EMBO J. 2024;43(20):4492\u2013521. https:\/\/doi.org\/10.1038\/s44318-024-00176-4.","journal-title":"EMBO J"},{"key":"1344_CR42","doi-asserted-by":"publisher","first-page":"1441338","DOI":"10.3389\/fonc.2024.1441338","volume":"14","author":"GL Lupica-Tondo","year":"2024","unstructured":"Lupica-Tondo GL, et al Immunometabolism of ferroptosis in the tumor microenvironment. Front Oncol. 2024;14:1441338. https:\/\/doi.org\/10.3389\/fonc.2024.1441338.","journal-title":"Front Oncol"},{"issue":"1","key":"1344_CR43","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s13046-024-03235-0","volume":"43","author":"K Cui","year":"2024","unstructured":"Cui K, Wang K, Huang Z. Ferroptosis and the tumor microenvironment. J Exp Clin Cancer Res. 2024;43(1):315. https:\/\/doi.org\/10.1186\/s13046-024-03235-0.","journal-title":"J Exp Clin Cancer Res"},{"issue":"7755","key":"1344_CR44","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang W, Green M, Choi JE, Gij\u00f3n M, Kennedy PD, Johnson JK, Liao P, Lang X, Kryczek I, Sell A, Xia H, Zhou J, Li G, Li J, Li W, Wei S, Vatan L, Zhang H, Szeliga W, Gu W, et al. CD8\u2009+\u2009T cells regulate tumour ferroptosis during cancer immunotherapy. Nature. 2019;569(7755):270\u20134. https:\/\/doi.org\/10.1038\/s41586-019-1170-y.","journal-title":"Nature"},{"issue":"4","key":"1344_CR45","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","volume":"40","author":"P Liao","year":"2022","unstructured":"Liao P, Wang W, Wang W, Kryczek I, Li X, Bian Y, Sell A, Wei S, Grove S, Johnson JK, Kennedy PD, Gij\u00f3n M, Shah YM, Zou W. CD8\u2009+\u2009T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell. 2022;40(4):365\u2013e3786. https:\/\/doi.org\/10.1016\/j.ccell.2022.02.003.","journal-title":"Cancer Cell"},{"key":"1344_CR46","doi-asserted-by":"publisher","first-page":"1650219","DOI":"10.3389\/fonc.2025.1650219","volume":"15","author":"W Gao","year":"2025","unstructured":"Gao W, Tan J, Yu C Ferroptosis in the tumor microenvironment: mechanisms, advances, and therapeutic perspectives. Front Oncol. 2025;15:1650219. https:\/\/doi.org\/10.3389\/fonc.2025.1650219.","journal-title":"Front Oncol"},{"issue":"5","key":"1344_CR47","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.trecan.2024.01.013","volume":"10","author":"E Catanzaro","year":"2024","unstructured":"Catanzaro E, Demuynck R, Naessens F, Galluzzi L, Krysko DV. Immunogenicity of ferroptosis in cancer: A matter of context? Trends Cancer. 2024;10(5):407\u201316. https:\/\/doi.org\/10.1016\/j.trecan.2024.01.013.","journal-title":"Trends Cancer"},{"issue":"1","key":"1344_CR48","doi-asserted-by":"publisher","first-page":"1862949","DOI":"10.1080\/2162402X.2020.1862949","volume":"10","author":"D Tang","year":"2020","unstructured":"Tang D, Kepp O, Kroemer G. Ferroptosis becomes immunogenic: implications for anticancer treatments. OncoImmunology. 2020;10(1):1862949. https:\/\/doi.org\/10.1080\/2162402X.2020.1862949.","journal-title":"OncoImmunology"},{"issue":"12","key":"1344_CR49","doi-asserted-by":"publisher","first-page":"e003430","DOI":"10.1136\/jitc-2021-003430","volume":"9","author":"R Demuynck","year":"2021","unstructured":"Demuynck R, Efimova I, Naessens F, Krysko DV. Immunogenic ferroptosis and where to find it? J Immunother Cancer. 2021;9(12):e003430. https:\/\/doi.org\/10.1136\/jitc-2021-003430.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"1344_CR50","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1038\/s41467-022-31218-2","volume":"13","author":"B Wiernicki","year":"2022","unstructured":"Wiernicki B, Maschalidi S, Pinney J, Adjemian S, Vanden Berghe T, Ravichandran KS, Vandenabeele P Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity. Nat Commun. 2022;13(1):3676. https:\/\/doi.org\/10.1038\/s41467-022-31218-2.","journal-title":"Nat Commun"},{"key":"1344_CR51","doi-asserted-by":"publisher","first-page":"103796","DOI":"10.1016\/j.redox.2025.103796","volume":"86","author":"J Zhu","year":"2025","unstructured":"Zhu J, Li X, Chen W, Zuo Z, Gong Q, Hu J, et al. Ferroptosis triggers anti-tumor immunity via promoting chaperone-mediated autophagic degradation of SHP2. Redox Biol. 2025;86:103796. https:\/\/doi.org\/10.1016\/j.redox.2025.103796.","journal-title":"Redox Biol"},{"key":"1344_CR52","doi-asserted-by":"publisher","first-page":"1188365","DOI":"10.3389\/fimmu.2023.1188365","volume":"14","author":"D Qi","year":"2023","unstructured":"Qi D, Peng M Ferroptosis-mediated immune responses in cancer. Front Immunol. 2023;14:1188365. https:\/\/doi.org\/10.3389\/fimmu.2023.1188365.","journal-title":"Front Immunol"},{"issue":"720","key":"1344_CR53","doi-asserted-by":"publisher","first-page":"eadg3049","DOI":"10.1126\/scitranslmed.adg3049","volume":"15","author":"J Li","year":"2023","unstructured":"Li J, Liu J, Zhou Z, Wu R, Chen X, Yu C, Stockwell BR, Kroemer G, Kang R, Tang D. Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer. Sci Transl Med. 2023;15(720):eadg3049. https:\/\/doi.org\/10.1126\/scitranslmed.adg3049.","journal-title":"Sci Transl Med"},{"issue":"5","key":"1344_CR54","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.immuni.2024.03.019","volume":"57","author":"HN Bell","year":"2024","unstructured":"Bell HN, Stockwell BR, Zou W. Ironing out the role of ferroptosis in immunity. Immunity. 2024;57(5):941\u201356. https:\/\/doi.org\/10.1016\/j.immuni.2024.03.019.","journal-title":"Immunity"},{"key":"1344_CR55","doi-asserted-by":"publisher","first-page":"1109037","DOI":"10.3389\/fonc.2023.1109037","volume":"13","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wu Z, Feng Y, Gao J, Wang B, Lian C, Diao B. Integration analysis of single-cell and spatial transcriptomics reveal the cellular heterogeneity landscape in glioblastoma and establish a polygenic risk model. Front Oncol. 2023;13:1109037. https:\/\/doi.org\/10.3389\/fonc.2023.1109037.","journal-title":"Front Oncol"},{"issue":"5","key":"1344_CR56","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","volume":"33","author":"X Ma","year":"2021","unstructured":"Ma X, Xiao L, Liu L, Ye L, Su P, Bi E, Wang Q, Yang M, Qian J, Yi Q. CD36-mediated ferroptosis dampens intratumoral CD8\u2009+\u2009T cell effector function and impairs their antitumor ability. Cell Metabol. 2021;33(5):1001\u2013e10125. https:\/\/doi.org\/10.1016\/j.cmet.2021.02.015.","journal-title":"Cell Metabol"},{"issue":"10","key":"1344_CR57","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/cac2.12487","volume":"43","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Sun L, Guo J, Ma J. The crosstalk between ferroptosis and anti-tumor immunity in the tumor microenvironment: molecular mechanisms and therapeutic controversy. Cancer Commun. 2023;43(10):1071\u201396. https:\/\/doi.org\/10.1002\/cac2.12487.","journal-title":"Cancer Commun"},{"issue":"7545","key":"1344_CR58","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","volume":"520","author":"L Jiang","year":"2015","unstructured":"Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, Baer R, Gu W. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520(7545):57\u201362. https:\/\/doi.org\/10.1038\/nature14344.","journal-title":"Nature"},{"key":"1344_CR59","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1038\/s41467-023-39401-9","volume":"14","author":"Y Yan","year":"2023","unstructured":"Yan Y, Teng H, Hang Q, et al. SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells. Nat Commun. 2023;14:3673. https:\/\/doi.org\/10.1038\/s41467-023-39401-9.","journal-title":"Nat Commun"},{"key":"1344_CR60","doi-asserted-by":"publisher","first-page":"176124","DOI":"10.1016\/j.ejphar.2023.176124","volume":"961","author":"W Zhu","year":"2023","unstructured":"Zhu W, Liu X, Yang L, He Q, Huang D, Tan X Ferroptosis and tumor immunity: In perspective of the major cell components in the tumor microenvironment. Eur J Pharmacol. 2023;961:176124. https:\/\/doi.org\/10.1016\/j.ejphar.2023.176124.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"1344_CR61","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","volume":"31","author":"DF Quail","year":"2017","unstructured":"Quail DF, Joyce JA. The microenvironmental landscape of brain tumors. Cancer Cell. 2017;31(3):326\u201341. https:\/\/doi.org\/10.1016\/j.ccell.2017.02.009.","journal-title":"Cancer Cell"},{"issue":"1","key":"1344_CR62","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nn.4185","volume":"19","author":"D Hambardzumyan","year":"2016","unstructured":"Hambardzumyan D, Gutmann DH, Kettenmann H. The role of microglia and macrophages in glioma maintenance and progression. Nat Neurosci. 2016;19(1):20\u20137. https:\/\/doi.org\/10.1038\/nn.4185.","journal-title":"Nat Neurosci"},{"key":"1344_CR63","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","volume":"20","author":"CD Arvanitis","year":"2020","unstructured":"Arvanitis CD, Ferraro GB, Jain RK. The blood\u2013brain barrier and blood\u2013tumour barrier in brain tumours and metastases. Nat Rev Cancer. 2020;20:26\u201341. https:\/\/doi.org\/10.1038\/s41568-019-0205-x.","journal-title":"Nat Rev Cancer"},{"key":"1344_CR64","doi-asserted-by":"publisher","first-page":"917634","DOI":"10.3389\/fonc.2022.917634","volume":"12","author":"K Wang","year":"2022","unstructured":"Wang K, Wang J, Zhang J, Zhang A, Liu Y, Zhou J, Wang X, Zhang J. Ferroptosis in glioma immune microenvironment: opportunity and challenge. Front Oncol. 2022;12:917634. https:\/\/doi.org\/10.3389\/fonc.2022.917634.","journal-title":"Front Oncol"},{"key":"1344_CR65","doi-asserted-by":"publisher","first-page":"989896","DOI":"10.3389\/fonc.2022.989896","volume":"12","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Shen Y, Chen C, Sui X, Yang J, Wang Y, Bian J, Wang J, Zhang X. Ferroptosis in glioma treatment: current situation, prospects and drug applications. Front Oncol. 2022;12:989896. https:\/\/doi.org\/10.3389\/fonc.2022.989896.","journal-title":"Front Oncol"},{"key":"1344_CR66","doi-asserted-by":"publisher","first-page":"149045","DOI":"10.1016\/j.brainres.2024.149045","volume":"1840","author":"SY Kim","year":"2024","unstructured":"Kim SY, Tang M, Lu T, Chih SY, Li W. Ferroptosis in glioma therapy: advancements in sensitizing strategies and the complex tumor-promoting roles. Brain Res. 2024;1840:149045. https:\/\/doi.org\/10.1016\/j.brainres.2024.149045.","journal-title":"Brain Res"},{"issue":"11","key":"1344_CR67","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","volume":"32","author":"WM Pardridge","year":"2012","unstructured":"Pardridge WM. Drug transport across the blood\u2013brain barrier. J Cereb Blood Flow Metabolism. 2012;32(11):1959\u201372. https:\/\/doi.org\/10.1038\/jcbfm.2012.126.","journal-title":"J Cereb Blood Flow Metabolism"},{"issue":"1","key":"1344_CR68","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/antiox14010096","volume":"14","author":"C Desterke","year":"2025","unstructured":"Desterke C, Fu Y, Bonifacio-Mundaca J, Monge C, Pineau P, Mata-Garrido J, Franc\u00e9s R Ferroptosis transcriptional regulation and prognostic impact in medulloblastoma subtypes revealed by RNA-seq. Antioxidants. 2025;14(1):96. https:\/\/doi.org\/10.3390\/antiox14010096.","journal-title":"Antioxidants"},{"issue":"4","key":"1344_CR69","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/path.6245","volume":"262","author":"H Zhou","year":"2024","unstructured":"Zhou H, Wang YX, Wu M, Lan X, Xiang D, Cai R, Ma Q, Miao J, Fang X, Wang J, Luo D, He Z, Cui Y, Liang P, Wang Y, Bian XW. FANCD2 deficiency sensitizes SHH medulloblastoma to radiotherapy via ferroptosis. J Pathol. 2024;262(4):427\u201340. https:\/\/doi.org\/10.1002\/path.6245.","journal-title":"J Pathol"},{"issue":"12","key":"1344_CR70","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1093\/neuonc\/noab114","volume":"23","author":"Z Bao","year":"2021","unstructured":"Bao Z, Hua L, Ye Y, Wang D, Li C, Xie Q, Wakimoto H, Gong Y, Ji J. MEF2C silencing downregulates NF2 and E-cadherin and enhances erastin-induced ferroptosis in meningioma. Neurooncology. 2021;23(12):2014\u201327. https:\/\/doi.org\/10.1093\/neuonc\/noab114.","journal-title":"Neurooncology"},{"key":"1344_CR71","doi-asserted-by":"publisher","first-page":"103137","DOI":"10.1016\/j.redox.2024.103137","volume":"72","author":"Y Ye","year":"2024","unstructured":"Ye Y, Xu L, Zhang L, Zhao P, Cai W, Fu G, Wang T, Tao Z, Shi W, Gu W, Hu J, Yuan G, Wei Y, Xu K, Bao Z, Chao H, Liu N, Zhao L, Tu Y, Ji J Meningioma achieves malignancy and Erastin-induced ferroptosis resistance through FOXM1\u2013AURKA\u2013NRF2 axis. Redox Biol. 2024;72:103137. https:\/\/doi.org\/10.1016\/j.redox.2024.103137.","journal-title":"Redox Biol"},{"issue":"2","key":"1344_CR72","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s11060-024-04918-6","volume":"172","author":"Q Dai","year":"2025","unstructured":"Dai Q, Wei J, Li Z, Li T, Fang Y, Li X, Shen B, Xie Q, Wang M, Wu W. Mifepristone achieves tumor suppression and ferroptosis through PR\/p53\/HO1\/GPX4 axis in meningioma cells. J Neurooncol. 2025;172(2):377\u201386. https:\/\/doi.org\/10.1007\/s11060-024-04918-6.","journal-title":"J Neurooncol"},{"key":"1344_CR73","doi-asserted-by":"publisher","first-page":"783067","DOI":"10.3389\/fonc.2021.783067","volume":"11","author":"M Dahlmanns","year":"2021","unstructured":"Dahlmanns M, Yakubov E, Dahlmanns JK. Genetic profiles of ferroptosis in malignant brain tumors and off-target effects of ferroptosis induction. Front Oncol. 2021;11:783067. https:\/\/doi.org\/10.3389\/fonc.2021.783067.","journal-title":"Front Oncol"},{"issue":"1","key":"1344_CR74","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40478-024-01769-0","volume":"12","author":"M Liu","year":"2024","unstructured":"Liu M, Ji Z, Jain V, Smith VL, Hocke E, Patel AP, McLendon RE, Ashley DM, Gregory SG, L\u00f3pez GY Spatial transcriptomics reveals segregation of tumor cell states in glioblastoma and marked immunosuppression within the perinecrotic niche. Acta Neuropathol Commun. 2024;12(1):64. https:\/\/doi.org\/10.1186\/s40478-024-01769-0.","journal-title":"Acta Neuropathol Commun"},{"key":"1344_CR75","doi-asserted-by":"publisher","first-page":"1452172","DOI":"10.3389\/fimmu.2024.1452172","volume":"15","author":"Z He","year":"2024","unstructured":"He Z, Liu Z, Wang Q, Sima X, Zhao W, He C, Yang W, Chen H, Gong B, Song S, Wang Y Single-cell and spatial transcriptome assays reveal heterogeneity in gliomas through stress responses and pathway alterations. Front Immunol. 2024;15:1452172. https:\/\/doi.org\/10.3389\/fimmu.2024.1452172.","journal-title":"Front Immunol"},{"issue":"4","key":"1344_CR76","doi-asserted-by":"publisher","first-page":"189383","DOI":"10.1016\/j.bbcan.2025.189383","volume":"1880","author":"S Saha","year":"2025","unstructured":"Saha S, Bhat A, Kukal S, Phalak M, Kumar S Spatial heterogeneity in glioblastoma: decoding the role of perfusion. Biochim et Biophys Acta Rev Cancer. 2025;1880(4):189383. https:\/\/doi.org\/10.1016\/j.bbcan.2025.189383.","journal-title":"Biochim et Biophys Acta Rev Cancer"},{"key":"1344_CR77","doi-asserted-by":"publisher","first-page":"1037896","DOI":"10.3389\/fonc.2022.1037896","volume":"12","author":"M Van Waqar","year":"2022","unstructured":"Waqar M, Van Houdt PJ, Hessen E, Li KL, Zhu X, Jackson A, Iqbal M, O\u2019Connor J, Djoukhadar I, van der Heide UA, Coope DJ, Borst GR Visualising spatial heterogeneity in glioblastoma using imaging habitats. Front Oncol. 2022;12:1037896. https:\/\/doi.org\/10.3389\/fonc.2022.1037896.","journal-title":"Front Oncol"},{"issue":"12","key":"1344_CR78","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1007\/s00259-024-06782-y","volume":"51","author":"J Ziegenfeuter","year":"2024","unstructured":"Ziegenfeuter J, Delbridge C, Bernhardt D, Gempt J, Schmidt-Graf F, Hedderich D, Griessmair M, Thomas M, Meyer HS, Zimmer C, Meyer B, Combs SE, Yakushev I, Metz MC, Wiestler B. Resolving spatial response heterogeneity in glioblastoma. Eur J Nucl Med Mol Imaging. 2024;51(12):3685\u201395. https:\/\/doi.org\/10.1007\/s00259-024-06782-y.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"1344_CR79","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.3390\/antiox11112123","volume":"11","author":"Y Luo","year":"2022","unstructured":"Luo Y, Tian G, Fang X, Bai S, Yuan G, Pan Y. Ferroptosis and its potential role in glioma: from molecular mechanisms to therapeutic opportunities. Antioxidants. 2022;11(11):2123. https:\/\/doi.org\/10.3390\/antiox11112123.","journal-title":"Antioxidants"},{"key":"1344_CR80","doi-asserted-by":"publisher","first-page":"974156","DOI":"10.3389\/fmolb.2022.974156","volume":"9","author":"S Zhuo","year":"2022","unstructured":"Zhuo S, He G, Chen T, Li X, Liang Y, Wu W, Weng L, Feng J, Gao Z, Yang K. Emerging role of ferroptosis in glioblastoma: therapeutic opportunities and challenges. Front Mol Biosci. 2022;9:974156. https:\/\/doi.org\/10.3389\/fmolb.2022.974156.","journal-title":"Front Mol Biosci"},{"issue":"7","key":"1344_CR81","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1007\/s10571-021-01092-5","volume":"42","author":"R Huang","year":"2022","unstructured":"Huang R, Dong R, Wang N, He Y, Zhu P, Wang C, Lan B, Gao Y, Sun L. Adaptive changes allow targeting of ferroptosis for glioma treatment. Cell Mol Neurobiol. 2022;42(7):2055\u201374. https:\/\/doi.org\/10.1007\/s10571-021-01092-5.","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"1344_CR82","doi-asserted-by":"publisher","first-page":"20770","DOI":"10.1038\/s41598-024-72024-8","volume":"14","author":"S D\u2019Aprile","year":"2024","unstructured":"D\u2019Aprile S, Denaro S, Lavoro A, Candido S, Giallongo S, Torrisi F, Salvatorelli L, Lazzarino G, Amorini AM, Magro G, Tibullo D, Libra M, Giallongo C, Vicario N, Parenti R Glioblastoma mesenchymal subtype enhances antioxidant defence to reduce susceptibility to ferroptosis. Sci Rep. 2024;14(1):20770. https:\/\/doi.org\/10.1038\/s41598-024-72024-8.","journal-title":"Sci Rep"},{"issue":"9\u201310","key":"1344_CR83","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1101\/gad.351427.123","volume":"38","author":"RD Read","year":"2024","unstructured":"Read RD, Tapp ZM, Rajappa P, Hambardzumyan D. Glioblastoma microenvironment: from biology to therapy. Genes Dev. 2024;38(9\u201310):360\u201379. https:\/\/doi.org\/10.1101\/gad.351427.123.","journal-title":"Genes Dev"},{"issue":"11","key":"1344_CR84","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.3390\/cells10112981","volume":"10","author":"E El Cosialls","year":"2021","unstructured":"Cosialls E, El Hage R, Dos Santos L, Gong C, Mehrpour M, Hama\u00ef A, Ferroptosis Cancer stem cells rely on iron until to die for it. Cells. 2021;10(11):2981. https:\/\/doi.org\/10.3390\/cells10112981.","journal-title":"Cells"},{"issue":"4","key":"1344_CR85","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.cell.2023.01.020","volume":"186","author":"J Zhao","year":"2023","unstructured":"Zhao J, Jia Y, Mahmut D, Deik AA, Jeanfavre S, Clish CB, Sankaran VG. Human hematopoietic stem cell vulnerability to ferroptosis. Cell. 2023;186(4):732\u2013e74716. https:\/\/doi.org\/10.1016\/j.cell.2023.01.020.","journal-title":"Cell"},{"key":"1344_CR86","doi-asserted-by":"publisher","first-page":"10631","DOI":"10.2147\/OTT.S272312","volume":"13","author":"C Qiu","year":"2020","unstructured":"Qiu C, Zhang X, Huang B, Wang S, Zhou W, Li C, Li X, Wang J, Yang N. Disulfiram, a ferroptosis inducer, triggers lysosomal membrane permeabilization by up-regulating ROS in glioblastoma. OncoTargets Therapy. 2020;13:10631\u201340. https:\/\/doi.org\/10.2147\/OTT.S272312.","journal-title":"OncoTargets Therapy"},{"issue":"2","key":"1344_CR87","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s11011-022-00983-w","volume":"38","author":"C Hacioglu","year":"2023","unstructured":"Hacioglu C, Kar F. Capsaicin induces redox imbalance and ferroptosis through ACSL4\/GPx4 signaling pathways in U87-MG and U251 glioblastoma cells. Metab Brain Dis. 2023;38(2):393\u2013408. https:\/\/doi.org\/10.1007\/s11011-022-00983-w.","journal-title":"Metab Brain Dis"},{"issue":"9","key":"1344_CR88","doi-asserted-by":"publisher","first-page":"7706","DOI":"10.3390\/ijms24097706","volume":"24","author":"IC Su","year":"2023","unstructured":"Su IC, Su YK, Setiawan SA, Yadav VK, Fong IH, Yeh CT, Lin CM, Liu HW NADPH oxidase subunit CYBB confers chemotherapy and ferroptosis resistance in mesenchymal glioblastoma via Nrf2\/SOD2 modulation. Int J Mol Sci. 2023;24(9):7706. https:\/\/doi.org\/10.3390\/ijms24097706.","journal-title":"Int J Mol Sci"},{"key":"1344_CR89","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1186\/s12951-024-03005-2","volume":"22","author":"Y Feng","year":"2024","unstructured":"Feng Y, Tang Q, Wang B, et al Targeting the tumor microenvironment with biomaterials for enhanced immunotherapeutic efficacy. J Nanobiotechnol. 2024;22:737. https:\/\/doi.org\/10.1186\/s12951-024-03005-2.","journal-title":"J Nanobiotechnol"},{"key":"1344_CR90","doi-asserted-by":"publisher","first-page":"1085034","DOI":"10.3389\/fonc.2022.1085034","volume":"12","author":"A Bezawork-Geleta","year":"2022","unstructured":"Bezawork-Geleta A, Dimou J, Watt MJ. Lipid droplets and ferroptosis as new players in brain cancer glioblastoma progression and therapeutic resistance. Front Oncol. 2022;12:1085034. https:\/\/doi.org\/10.3389\/fonc.2022.1085034.","journal-title":"Front Oncol"},{"issue":"12","key":"1344_CR91","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.3390\/antiox14121474","volume":"14","author":"MN Park","year":"2025","unstructured":"Park MN, Choi J, Ribeiro RIMA, Delfino DV, Ko SG, Kim B The redox\u2013adhesion\u2013exosome (RAX) hub in cancer: Lipid peroxidation-driven EMT plasticity and ferroptosis defense with HNE\/MDA signaling and lipidomic perspectives. Antioxidants. 2025;14(12):1474. https:\/\/doi.org\/10.3390\/antiox14121474.","journal-title":"Antioxidants"},{"key":"1344_CR92","doi-asserted-by":"publisher","first-page":"590861","DOI":"10.3389\/fonc.2020.590861","volume":"10","author":"S Zhuo","year":"2020","unstructured":"Zhuo S, Chen Z, Yang Y, Zhang J, Tang J, Yang K. Clinical and biological significances of a ferroptosis-related gene signature in glioma. Front Oncol. 2020;10:590861. https:\/\/doi.org\/10.3389\/fonc.2020.590861.","journal-title":"Front Oncol"},{"key":"1344_CR93","doi-asserted-by":"publisher","first-page":"898679","DOI":"10.3389\/fphar.2022.898679","volume":"13","author":"X Zhang","year":"2022","unstructured":"Zhang X, Jin S, Shi X, Liu S, Li K, Liu G, Zhong S, Liu T, Li L, Tao S, Zhai Q, Bao N, Ren L, Wu Y, Bao Y. Modulation of tumor immune microenvironment and prognostic value of ferroptosis-related genes, and candidate target drugs in glioblastoma multiforme. Front Pharmacol. 2022;13:898679. https:\/\/doi.org\/10.3389\/fphar.2022.898679.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1344_CR94","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12964-023-01108-1","volume":"21","author":"S Wan","year":"2023","unstructured":"Wan S, Zhang G, Liu R, Abbas MN, Cui H. Pyroptosis, ferroptosis, and autophagy cross-talk in glioblastoma opens up new avenues for glioblastoma treatment. Cell Commun Signal. 2023;21(1):115. https:\/\/doi.org\/10.1186\/s12964-023-01108-1.","journal-title":"Cell Commun Signal"},{"issue":"3","key":"1344_CR95","doi-asserted-by":"publisher","first-page":"e42242","DOI":"10.1016\/j.heliyon.2025.e42242","volume":"11","author":"X Zheng","year":"2025","unstructured":"Zheng X, Diao M, Tong S, Yang S, Lin J, Zhuo S, Wang T, Dai J, Chen S, Wang K. Global research landscape and hotspots for ferroptosis in glioma: a comprehensive bibliometric and visual analysis. Heliyon. 2025;11(3):e42242. https:\/\/doi.org\/10.1016\/j.heliyon.2025.e42242.","journal-title":"Heliyon"},{"issue":"3","key":"1344_CR96","doi-asserted-by":"publisher","first-page":"116965","DOI":"10.1016\/j.celrep.2026.116965","volume":"45","author":"SZ Wang","year":"2026","unstructured":"Wang SZ, Timken JP, Hong ES, Kaur S, Newby E, Kay KE, Mulkearns-Hubert EE, Silver DJ, Lee J, Rubin JB, Connor JR, Deleyrolle LP, Tiek D, Dhawan A, Lathia JD. Lipocalin 2 orchestrates resistance to ferroptosis via AXL. Cell Rep. 2026;45(3):116965. https:\/\/doi.org\/10.1016\/j.celrep.2026.116965.","journal-title":"Cell Rep"},{"key":"1344_CR97","doi-asserted-by":"publisher","first-page":"2915019","DOI":"10.1155\/2021\/2915019","volume":"2021","author":"S Li","year":"2021","unstructured":"Li S, et al. RSL3 drives ferroptosis through NF-\u03baB pathway activation and GPX4 depletion in glioblastoma. Oxid Med Cell Longev. 2021;2021:2915019. https:\/\/doi.org\/10.1155\/2021\/2915019.","journal-title":"Oxid Med Cell Longev"},{"issue":"22","key":"1344_CR98","doi-asserted-by":"publisher","first-page":"6610","DOI":"10.7150\/jca.58500","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang X, et al. FIN56, a novel ferroptosis inducer, triggers lysosomal membrane permeabilization in a TFEB-dependent manner in glioblastoma. J Cancer. 2021;12(22):6610\u20139. https:\/\/doi.org\/10.7150\/jca.58500.","journal-title":"J Cancer"},{"issue":"1\u20132","key":"1344_CR99","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156(1\u20132):317\u201331. https:\/\/doi.org\/10.1016\/j.cell.2013.12.010.","journal-title":"Cell"},{"issue":"10","key":"1344_CR100","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1111\/cts.13604","volume":"16","author":"H Yu","year":"2023","unstructured":"Yu H, et al. TXNDC12 knockdown promotes ferroptosis by modulating SLC7A11 expression in glioma. Clin Transl Sci. 2023;16(10):1957\u201371. https:\/\/doi.org\/10.1111\/cts.13604.","journal-title":"Clin Transl Sci"},{"key":"1344_CR101","doi-asserted-by":"publisher","first-page":"174860","DOI":"10.1016\/j.ejphar.2022.174860","volume":"921","author":"H Chen","year":"2022","unstructured":"Chen H, Wen J. Iron oxide nanoparticles loaded with paclitaxel inhibits glioblastoma by enhancing autophagy-dependent ferroptosis pathway. Eur J Pharmacol. 2022;921:174860. https:\/\/doi.org\/10.1016\/j.ejphar.2022.174860.","journal-title":"Eur J Pharmacol"},{"issue":"39","key":"1344_CR102","doi-asserted-by":"publisher","first-page":"43408","DOI":"10.1021\/acsami.0c12042","volume":"12","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, et al. Glioblastoma therapy using codelivery of cisplatin and glutathione peroxidase\u2013targeting siRNA from iron oxide nanoparticles. ACS Appl Mater Interfaces. 2020;12(39):43408\u201321. https:\/\/doi.org\/10.1021\/acsami.0c12042.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1344_CR103","doi-asserted-by":"publisher","first-page":"101413","DOI":"10.1016\/j.redox.2019.101413","volume":"30","author":"T-C Chen","year":"2020","unstructured":"Chen T-C, et al. AR ubiquitination induced by the curcumin analog suppresses growth of temozolomide-resistant glioblastoma through disrupting GPX4-mediated redox homeostasis. Redox Biol. 2020;30:101413. https:\/\/doi.org\/10.1016\/j.redox.2019.101413.","journal-title":"Redox Biol"},{"issue":"9","key":"1344_CR104","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3349\/ymj.2021.62.9.843","volume":"62","author":"Q Song","year":"2021","unstructured":"Song Q, et al. Temozolomide drives ferroptosis via a DMT1-dependent pathway in glioblastoma cells. Yonsei Med J. 2021;62(9):843. https:\/\/doi.org\/10.3349\/ymj.2021.62.9.843.","journal-title":"Yonsei Med J"},{"issue":"46","key":"1344_CR105","doi-asserted-by":"publisher","first-page":"74630","DOI":"10.18632\/oncotarget.11858","volume":"7","author":"T Sehm","year":"2016","unstructured":"Sehm T, et al. Temozolomide toxicity operates in a xCT\/SLC7A11-dependent manner and is fostered by ferroptosis. Oncotarget. 2016;7(46):74630\u201347. https:\/\/doi.org\/10.18632\/oncotarget.11858.","journal-title":"Oncotarget"},{"issue":"2","key":"1344_CR106","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1021\/acschembio.9b00939","volume":"15","author":"LF Ye","year":"2020","unstructured":"Ye LF, et al. Radiation-induced lipid peroxidation triggers ferroptosis and synergizes with ferroptosis inducers. ACS Chem Biol. 2020;15(2):469\u201384. https:\/\/doi.org\/10.1021\/acschembio.9b00939.","journal-title":"ACS Chem Biol"},{"issue":"8","key":"1344_CR107","doi-asserted-by":"publisher","first-page":"e139434","DOI":"10.1172\/JCI139434","volume":"131","author":"Z Jiang","year":"2021","unstructured":"Jiang Z, et al. TYRO3 induces anti\u2013PD-1\/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis. J Clin Invest. 2021;131(8):e139434. https:\/\/doi.org\/10.1172\/JCI139434.","journal-title":"J Clin Invest"},{"key":"1344_CR108","doi-asserted-by":"publisher","first-page":"5779","DOI":"10.2147\/IJN.S523008","volume":"20","author":"L Jing","year":"2025","unstructured":"Jing L, Xiao W, Hu Z, Liu X, Yuan M. A systematic review of nanoparticle-mediated ferroptosis in glioma therapy. Int J Nanomed. 2025;20:5779\u201397. https:\/\/doi.org\/10.2147\/IJN.S523008.","journal-title":"Int J Nanomed"},{"key":"1344_CR109","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.2147\/IJN.S243223","volume":"15","author":"J Li","year":"2020","unstructured":"Li J, et al. Nanoparticle drug delivery system for glioma and its efficacy improvement strategies: a comprehensive review. Int J Nanomed. 2020;15:2563\u201382. https:\/\/doi.org\/10.2147\/IJN.S243223.","journal-title":"Int J Nanomed"},{"key":"1344_CR110","doi-asserted-by":"publisher","first-page":"817643","DOI":"10.3389\/fcell.2022.817643","volume":"10","author":"J Shi","year":"2022","unstructured":"Shi J, et al. Identification of ferroptosis-related biomarkers for prognosis and immunotherapy in patients with glioma. Front Cell Dev Biology. 2022;10:817643. https:\/\/doi.org\/10.3389\/fcell.2022.817643.","journal-title":"Front Cell Dev Biology"},{"key":"1344_CR111","doi-asserted-by":"publisher","first-page":"146473","DOI":"10.1016\/j.cej.2023.146473","volume":"475","author":"K Deng","year":"2023","unstructured":"Deng K, et al. Functional carbon dots induce ferroptosis by suppressing PLPP4 activity to inhibit glioblastoma growth. Chem Eng J. 2023;475:146473. https:\/\/doi.org\/10.1016\/j.cej.2023.146473.","journal-title":"Chem Eng J"},{"issue":"7784","key":"1344_CR112","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll S, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575(7784):693\u20138. https:\/\/doi.org\/10.1038\/s41586-019-1707-0.","journal-title":"Nature"},{"key":"1344_CR113","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cytogfr.2023.08.004","volume":"75","author":"X Zhai","year":"2024","unstructured":"Zhai X, et al. Ferroptosis in cancer immunity and immunotherapy: multifaceted interplay and clinical implications. Cytokine Growth Factor Rev. 2024;75:101\u20139. https:\/\/doi.org\/10.1016\/j.cytogfr.2023.08.004.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"12","key":"1344_CR114","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/s41568-025-00864-1","volume":"25","author":"A Wahida","year":"2025","unstructured":"Wahida A, Conrad M. Decoding ferroptosis for cancer therapy. Nat Rev Cancer. 2025;25(12):910\u201324. https:\/\/doi.org\/10.1038\/s41568-025-00864-1.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"1344_CR115","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/neuonc\/noac033","volume":"24","author":"T Liu","year":"2022","unstructured":"Liu T, Zhu C, Chen X, Guan G, Zou C, Shen S, Wu J, Wang Y, Lin Z, Chen L, Cheng P, Cheng W, Wu A. Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance. Neurooncology. 2022;24(7):1113\u201325. https:\/\/doi.org\/10.1093\/neuonc\/noac033.","journal-title":"Neurooncology"},{"issue":"4","key":"1344_CR116","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","volume":"178","author":"C Neftel","year":"2019","unstructured":"Neftel C, et al. An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell. 2019;178(4):835\u2013e84921. https:\/\/doi.org\/10.1016\/j.cell.2019.06.024.","journal-title":"Cell"},{"key":"1344_CR117","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.12688\/f1000research.126243.2","volume":"11","author":"A Perdyan","year":"2022","unstructured":"Perdyan A, \u0141awrynowicz U, Horbacz M, Kami\u0144ska B, Mieczkowski J. Integration of single-cell RNA sequencing and spatial transcriptomics to reveal the glioblastoma heterogeneity. F1000Research. 2022;11:1180. https:\/\/doi.org\/10.12688\/f1000research.126243.2.","journal-title":"F1000Research"},{"key":"1344_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2022.06.011","author":"ME Neganova","year":"2022","unstructured":"Neganova ME, Aleksandrova YR, Sukocheva OA, Klochkov SG. Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders. Semin Cancer Biol. 2022. https:\/\/doi.org\/10.1016\/j.semcancer.2022.06.011.","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"1344_CR119","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.3390\/cancers16061220","volume":"16","author":"M Piccolo","year":"2024","unstructured":"Piccolo M, Ferraro MG, Iazzetti F, Santamaria R, Irace C. Insight into iron, oxidative stress and ferroptosis: therapy targets for approaching anticancer strategies. Cancers. 2024;16(6):1220\u20131220. https:\/\/doi.org\/10.3390\/cancers16061220.","journal-title":"Cancers"},{"issue":"5","key":"1344_CR120","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ccr.2006.03.030","volume":"9","author":"J Lee","year":"2006","unstructured":"Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, Park JK, Fine HA. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell. 2006;9(5):391\u2013403. https:\/\/doi.org\/10.1016\/j.ccr.2006.03.030.","journal-title":"Cancer Cell"},{"issue":"7718","key":"1344_CR121","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41586-018-0409-3","volume":"560","author":"U Ben-David","year":"2018","unstructured":"Ben-David U, Siranosian B, Ha G, Tang H, Oren Y, Hinohara K, Strathdee CA, Dempster J, Lyons NJ, Burns R, Nag A, Kugener G, Cimini B, Tsvetkov P, Maruvka YE, O\u2019Rourke R, Garrity A, Tubelli AA, Bandopadhayay P, Tsherniak A. Genetic and transcriptional evolution alters cancer cell line drug response. Nature. 2018;560(7718):325\u201330. https:\/\/doi.org\/10.1038\/s41586-018-0409-3.","journal-title":"Nature"},{"key":"1344_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/8238459","volume":"2018","author":"JA Stuart","year":"2018","unstructured":"Stuart JA, Fonseca J, Moradi F, Cunningham C, Seliman B, Worsfold CR, Dolan S, Abando J, Maddalena LA. How supraphysiological oxygen levels in standard cell culture affect oxygen-consuming reactions. Oxid Med Cell Longev. 2018;2018:1\u201313. https:\/\/doi.org\/10.1155\/2018\/8238459.","journal-title":"Oxid Med Cell Longev"},{"issue":"11","key":"1344_CR123","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/ng.3967","volume":"49","author":"U Ben-David","year":"2017","unstructured":"Ben-David U, Ha G, Tseng Y-Y, Greenwald NF, Oh C, Shih J, McFarland JM, Wong B, Boehm JS, Beroukhim R, Golub TR. Patient-derived xenografts undergo murine-specific tumor evolution. Nature genetics. 2017;49(11):1567\u201375. https:\/\/doi.org\/10.1038\/ng.3967.","journal-title":"Nature genetics"},{"issue":"2","key":"1344_CR124","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1093\/neuonc\/noae195","volume":"27","author":"A Steindl","year":"2025","unstructured":"Steindl A, Valiente M. Potential of ex vivo organotypic slice cultures in neuro-oncology. Neurooncology. 2025;27(2):338\u201351. https:\/\/doi.org\/10.1093\/neuonc\/noae195.","journal-title":"Neurooncology"},{"issue":"9","key":"1344_CR125","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/s41591-018-0135-2","volume":"24","author":"P Chongsathidkiet","year":"2018","unstructured":"Chongsathidkiet P, Jackson C, Koyama S, Loebel F, Cui X, Farber SH, Woroniecka K, Elsamadicy AA, Dechant CA, Kemeny HR, Sanchez-Perez L, Cheema TA, Souders NC, Herndon JE, Coumans J-V, Everitt JI, Nahed BV, Sampson JH, Gunn MD, Martuza RL. Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors. Nat Med. 2018;24(9):1459\u201368. https:\/\/doi.org\/10.1038\/s41591-018-0135-2.","journal-title":"Nat Med"},{"issue":"7","key":"1344_CR126","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.cell.2020.04.055","volume":"181","author":"E Friebel","year":"2020","unstructured":"Friebel E, Kapolou K, Unger S, N\u00fa\u00f1ez NG, Utz S, Rushing EJ, Regli L, Weller M, Greter M, Tugues S, Neidert MC, Becher B. Single-cell mapping of human brain cancer reveals tumor-specific instruction of tissue-invading leukocytes. Cell. 2020;181(7):1626\u2013e164220. https:\/\/doi.org\/10.1016\/j.cell.2020.04.055.","journal-title":"Cell"}],"container-title":["Molecular Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13041-026-01344-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-026-01344-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-026-01344-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:42:59Z","timestamp":1787582579000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13041-026-01344-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":126,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1344"],"URL":"https:\/\/doi.org\/10.1186\/s13041-026-01344-9","relation":{},"ISSN":["1756-6606"],"issn-type":[{"value":"1756-6606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"assertion":[{"value":"11 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval is not applicable. No original data from new patients were collected, consent to participate is not applicable.","order":1,"name":"Ethics","label":"<b>Ethics approval and consent to participate<\/b>","group":{"name":"EthicsHeading","label":"<b>Declarations<\/b>"}},{"value":"Consent for publication is not applicable.","order":2,"name":"Ethics","label":"<b>Consent for publication<\/b>","group":{"name":"EthicsHeading","label":"<b>Declarations<\/b>"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"<b>Declarations<\/b>"}}],"article-number":"63"}}